When tirzepatide binds to GIP receptors, it triggers insulin release only when blood glucose is elevated, reducing hypoglycemia risk
"It's been around for 10 years, a long time as an injectable and now the most recent form is an inhalant, so a nasal spray," Tan said
Six people were arrested after investigators uncovered a factory, storage sites, and a fraud network
Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023), and it is also approved by the EMA
What is Klow peptide therapy
Pregnancy/Breastfeeding Vitamins from B group are generally recommended during pregnancy and breastfeeding as per individual requirement